Revista Brasileira de Hematologia e Hemoterapia · 2014 · 16 citations · 8 references
Veterinary MedicineImmunologyOncologyOral ImmunologyOral OncologyTransplant ImmunologyImmunosuppressionMalignant Oral TumorsOral CarcinogenesisOral Cavity CancerOral NeoplasiaSquamous Cell CarcinomaGraft-versus-host Disease PathophysiologyImmunosuppressant Drug ExposureMalignancy Risk Under ImmunosuppressionMalignant Oral LesionsOral Graft-versus-host DiseaseOral Lesion Malignant TransformationPotentially Malignant Oral DisordersTransplant-associated Malignancy
Long-term survivors of hematopoietic stem cell transplantation are recognized as a risk group for malignization. Malignant oral neoplasms are increasingly being reported in the literature as a consequence of lesions of chronic graft-versus-host disease, and prolonged multidrug treatment to control its manifestations. This report describes a 43-year-old patient who, after allogeneic bone marrow transplantation, developed an oral squamous cell carcinoma secondary to the use of azathioprine, cyclosporine, prednisone, and tacrolimus, associated with multiorgan chronic graft-versus-host disease involving the oral mucosa, skin, eyes, and liver. This report aims to discuss the possible role of immunosuppressant therapy for chronic graft-versus-host disease on the development of oral squamous cell carcinoma, and the relevance of a close oral follow-up of patients to detect dysplastic or malignant alterations at an early stage.
8
Solid Cancers after Bone Marrow Transplantation
Rochelle E. Curtis, Philip A. Rowlings, H. Joachim Deeg et al. · New England Journal of Medicine · 1997 · 968 citations · Full text
Solid Cancers After Bone Marrow Transplantation
Andrew D. Louie, Ravi Bhatia, Margaret O’Donnell et al. · Journal of Clinical Oncology · 2001 · 315 citations